Substitution or deletion mutations between nt 54 and 70 in the 5′ non-coding region of dengue type 2 virus produce variable effects on virus viability

Journal of General Virology

Volumn 88, Issue 6, 2007, Pages 1748-1752

  Sirigulpanit, Wipawan ^a   Kinney, Richard M ^b,c   Leardkamolkarn, Vijittra ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Public Health Consultant   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DENGUE VIRUS; GENE DELETION; GENE DISRUPTION; MOLECULAR CLONING; MOUSE; MUTANT; NEWBORN; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; RNA STRUCTURE; VIRUS REPLICATION; VIRUS VIABILITY; VIRUS VIRULENCE;

5' UNTRANSLATED REGIONS; ANIMALS; CELL LINE; CULICIDAE; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; MACACA MULATTA; MICE; MICE, INBRED ICR; MICROBIAL VIABILITY; NUCLEIC ACID CONFORMATION; POINT MUTATION; RNA, VIRAL; SEQUENCE DELETION; VIRULENCE; VIRUS REPLICATION; VIRUSES;

MUS;

EID: 34249806006     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82455-0     Document Type: Article

References (19)

1. All, N. & Siddiqui, A. (1995). Interaction of polypyrimidine tract-binding protein with the 5′ noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. J Virol 69, 6367-6375.
2. Alvarez, D. E., Lodeiro, M. F., Luduena, S. J., Pietrasanta, L. I. & Gamarnik, A. V. (2005). Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 79, 6631-6643.
3. Brinton, M. A. & Dispoto, J. H. (1988). Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA. Virology 162, 290-299.
4. Butrapet, S., Huang, C. Y., Pierro, D. J., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2000). Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5′ noncoding region and nonstructural proteins 1 and 3. J Virol 74, 3011-3019.
5. Butrapet, S., Kinney, R. M. & Huang, C. Y. (2006). Determining genetic stabilities of chimeric dengue vaccine candidates based on dengue 2 PDK-53 virus by sequencing and quantitative TaqMAMA. J Virol Methods 131, 1-9.
6. Cahour, A., Pletnev, A., Vazielle-Falcoz, M., Rosen, L. & Lai, C. J. (1995). Growth-restricted dengue virus mutants containing deletions in the 5′ noncoding region of the RNA genome. Virology 207, 68-76.
7. Filomatori, C. V., Lodeiro, M. F., Alvarez, D. E., Samsa, M. M., Pietrasanta, L. & Gamarnik, A. V. (2006). A 5′ RNA element promotes dengue virus RNA synthesis on a circular genome. Genes Dev 20, 2238-2249.
8. Gubler, D. J. (1998). Resurgent vector-borne diseases as a global health problem. Emerg Infect Dis 4, 442-450.
9. Guesdon, F. M., Greatorex, J., Rhee, S. R., Fisher, R., Hunter, E. & Lever, A. M. (2001). Sequences in the 5′ leader of Mason-Pfizer monkey virus which affect viral particle production and genomic RNA packaging: development of MPMV packaging cell lines. Virology 288, 81-88.
10. Huang, C. Y., Butrapet, S., Pierro, D. J., Chang, G. J, Hunt, A. R., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2000). Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol 74, 3020-3028.
11. Huang, C. Y., Butrapet, S., Tsuchiya, K. R., Bhamarapravati, N., Gubler, D. J. & Kinney, R. M. (2003). Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol 77, 11436-11447.
12. Huang, C. Y., Silengo, S. J., Whiteman, M. C. & Kinney, R. M. (2005). Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus. J Virol 79, 7300-7310.
13. Kinney, R. M., Butrapet, S., Chang, G. J., Tsuchiya, K. R., Roehrig, J. T., Bhamarapravati, N. & Gubler, D. J. (1997). Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology 230, 300-308.
14. Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E., Jones, C. T., Mukhopadhyay, S., Chipman, P. R. & other authors (2002). Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108, 717-725.
15. Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C. & Rico-Hesse, R. (1999). Dengue virus structural differences that correlate with pathogenesis. J Virol 73, 4738-4747.
16. Lindenbach, B. D. & Rice, C. M. (2003). Molecular biology of flaviviruses. Adv Virus Res 59, 23-61.
17. Miller, B. R. & Mitchell, C. J. (1986). Passage of yellow fever virus: its effect on infection and transmission rates in Aedes aegypti. Am J Trop Med Hyg 35, 1302-1309.
18. You, S., Falgout, B., Markoff, L. & Padmanabhan, R. (2001). In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5′- and 3′-terminal regions that influence RNA structure. J Biol Chem 276, 15581-15591.
19. Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31, 3406-3415.